Point-of-care diagnostics for tuberculosis elimination? – In this commentary published in The Lancet, Christian Wejse cites a recent randomized trial comparing point-of-care GeneXpert with smear microscopy in the management of TB to argue that instead of investing heavily to provide all peripheral health facilities in the world with GeneXpert, the same investment could ensure that […]
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]